首页> 外国专利> METHOD FOR PREDICTION OF RISK OF LIFE-THREATENING COMPLICATIONS IN PATIENTS IN ACUTE PERIOD OF MYOCARDIAL INFARCTION

METHOD FOR PREDICTION OF RISK OF LIFE-THREATENING COMPLICATIONS IN PATIENTS IN ACUTE PERIOD OF MYOCARDIAL INFARCTION

机译:心肌梗死急性期患者致命并发症风险的预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, particularly to therapy and cardiology. Presented is a method for predicting the risk of developing life-threatening complications in the patients suffering acute myocardial infarction. For prediction of cardiogenic shock or pulmonary oedema in patients with acute myocardial infarction, plasma levels of fractalkine, asymmetric dimethylarginine and transferrin are measured by enzyme immunoassay. Formula is used to calculate the probability of developing cardiogenic shock or pulmonary oedema. If p < 0.5, a low risk of developing cardiogenic shock or pulmonary oedema is predicted. If p ≥ 0.5, a high risk of developing cardiogenic shock or pulmonary oedema is predicted.;EFFECT: invention provides combined prediction of development of such life-threatening complications as pulmonary oedema and cardiogenic shock in patients with acute myocardial infarction, regardless of comorbidity.;1 cl, 3 ex
机译:领域:医学。;实质:发明指的是医学,尤其是治疗学和心脏病学。本文介绍了一种预测急性心肌梗死患者发生危及生命的并发症风险的方法。为了预测急性心肌梗死患者的心源性休克或肺水肿,采用酶免疫分析法测定血浆中fractalkine、不对称二甲基精氨酸和转铁蛋白的水平。公式用于计算发生心源性休克或肺水肿的概率。如果p<0.5,则预测发生心源性休克或肺水肿的风险较低。如果p≥0.5时,预计发生心源性休克或肺水肿的风险较高。;效果:本发明提供了对急性心肌梗死患者的肺水肿和心源性休克等危及生命的并发症发展的综合预测,而不考虑合并症。;1 cl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号